APVO -- Is Its Stock Price A Worthy Investment? Learn More. APVO Stock Summary. With a year-over-year growth in debt of -81.47%, Aptevo Therapeutics Inc's debt growth rate surpasses just 3.29% of about US stocks. As for revenue growth, note that APVO's revenue has grown 52.2% over the past 12 months; that beats the revenue growth of 89.94% of US companies in our set. Aptevo... (APVO) Stock Quote | Price Chart | Volume Chart

Mar 11, 2020 · SEATTLE--(BUSINESS WIRE)--August 01, 2016-- Aptevo Therapeutics Inc. ("Aptevo"; "the Company") (Nasdaq:APVO), a biotechnology company focused on developing novel oncology and hematology therapeutics, announced today that it has reached agreement with MidCap Financial on the final terms on a $35 million term loan. APVO Stock Quote - Aptevo Therapeutics, Inc. Stock Price Today Aptevo Therapeutics, Inc. is a biotechnology company, which engages in the discovery, development, commercialization and sale of novel oncology and hematology therapeutics to improve patients lives. Its pipeline includes APVO210, APVO436, ROR1 Candidate, and … Aptevo Therapeutics Inc. Stock Price (APVO) | Barron's Nov 08, 2019 · View today's stock price, news and analysis for Aptevo Therapeutics Inc. (APVO). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation

©2020 StockTwits, Inc. All rights reserved. Market Data by Xignite and BATS BZX Real-Time Price. Securities products and services offered to self-directed 

There will be NO CHANGE to the symbol. But to prevent 2) APTEVO THERAPEUTICS INC, APVO - 1 FOR 14 REVERSE STOCK SPLIT. Please note that  Oct 5, 2016 Divide by 20.2mm shares outstanding yields a stock price of $6.58. The stock currently trades at $2.59. Trubion Pharmaceutical. In 2010, EBS  This means shareholders will now hold 1 share of APVO for every 14 shares WisdomTree U.S. Total Market Fund (EXT) performed a ticker change to RESP,  a list of all companies on NASDAQ Stock Exchange including symbol and name. APVO, Aptevo Therapeutics Inc, 3.240, 3.058, 3.110, 70,300, -0.170, 5.18.

It was developed to show movements—or “ticks”—of a stock price on the New York Stock Exchange. Ticker tapes automatically recorded all trading activity on the 

Mar 11, 2020 · SEATTLE--(BUSINESS WIRE)--August 01, 2016-- Aptevo Therapeutics Inc. ("Aptevo"; "the Company") (Nasdaq:APVO), a biotechnology company focused on developing novel oncology and hematology therapeutics, announced today that it has reached agreement with MidCap Financial on the final terms on a $35 million term loan. APVO Stock Quote - Aptevo Therapeutics, Inc. Stock Price Today Aptevo Therapeutics, Inc. is a biotechnology company, which engages in the discovery, development, commercialization and sale of novel oncology and hematology therapeutics to improve patients lives. Its pipeline includes APVO210, APVO436, ROR1 Candidate, and … Aptevo Therapeutics Inc. Stock Price (APVO) | Barron's Nov 08, 2019 · View today's stock price, news and analysis for Aptevo Therapeutics Inc. (APVO). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation

View the latest APVO stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of APTEVO THERAPEUTICS INC..

View detailed financial information, real-time news, videos, quotes and analysis on Aptevo Therapeutics Inc. (NASDAQ:APVO). Explore commentary on Aptevo Therapeutics Inc. and hear what the experts APVO Stock Price Quote & News - Aptevo | Robinhood

Mar 30, 2020 · Learn about APVO with our data and independent analysis including price, star rating, valuation, dividends, and financials. Start a 14-day free trial to Morningstar Premium to unlock our take on APVO.

Aptevo Therapeutics Inc. Common Stock (APVO) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. APVO - Aptevo Therapeutics Inc Stock quote - CNNMoney.com Find real-time APVO - Aptevo Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. APVO - Aptevo Therapeutics Inc Stock quote - CNNMoney.com Markets

About APVO. Aptevo Therapeutics Inc. Common Stock, also called Aptevo, is a biotechnology company, which engages in the discovery, development, commercialization, and sale of novel oncology and hematology therapeutics to improve patients lives.